Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, ...

Sequencing of ctDNA was performed on blood samples through Guardant360 from the 243 patients with GIST (198 de-identified from the Guardant Health database and 45 from Sylvester Comprehensive Cancer ...

GI stromal tumors (GISTs) are neoplasms with widely variable malignant potential that arise from the GI tract, most frequently in the stomach. Their annual incidence is approximately 10 per million. 1 ...

Recent advances in cancer research have underscored the critical role of myeloid cells in shaping tumor microenvironments ...

A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...

Sanofi to acquire Blueprint Medicines for up to $9.5B to expand its rare immunological disease portfolio, including an ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

In South Texas, SpaceX is counting down to another attempted launch of its massive Starship rocket on Tuesday night. It comes ...

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

This is the second highest number after thyroid cancer.Gastric cancer refers to a malignant tumor in the stomach, mainly ...